ENDRA Life Sciences Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 11

Employees

  • Stock Symbol
  • NDRA

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $3.70
  • (As of Thursday Closing)

ENDRA Life Sciences General Information

Description

ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 3600 Green Court
  • Suite 350
  • Ann Arbor, MI 48105-1570
  • United States
+1 (734)
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Other Healthcare Technology Systems
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 3600 Green Court
  • Suite 350
  • Ann Arbor, MI 48105-1570
  • United States
+1 (734)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ENDRA Life Sciences Stock Performance

As of 19-Nov-2026, ENDRA Life Sciences’s stock price is $3.70. Its current market cap is $5.55M with 1.5M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.70 $4.04 $2.96 - $6.75 $5.55M 1.5M 29.4K -$5.25

ENDRA Life Sciences Financials Summary

As of 30-Sep-2026, ENDRA Life Sciences has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 7,628 5,015 (1,147) 15,023
Revenue 0 0 0 0
EBITDA (5,691) (6,870) (11,302) (9,785)
Net Income (5,849) (7,027) (11,508) (10,060)
Total Assets 6,723 3,854 4,452 6,754
Total Debt 397 492 584 394
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ENDRA Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ENDRA Life Sciences‘s full profile, request access.

Request a free trial

ENDRA Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore ENDRA Life Sciences‘s full profile, request access.

Request a free trial

ENDRA Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to impro
Diagnostic Equipment
Ann Arbor, MI
11 As of 2025

Bengaluru, India
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ENDRA Life Sciences Competitors (18)

One of ENDRA Life Sciences’s 18 competitors is SigTuple, a Venture Capital-Backed company based in Bengaluru, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SigTuple Venture Capital-Backed Bengaluru, India
TeraRecon Formerly VC-backed Durham, NC
Rivanna (Diagnostic Equipment) Venture Capital-Backed Charlottesville, VA
Niramai Venture Capital-Backed Bangalore, India
iCAD Corporate Backed or Acquired Nashua, NH
You’re viewing 5 of 18 competitors. Get the full list »

ENDRA Life Sciences Patents

ENDRA Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11994549-B1 Method and system to determine radio frequency antenna electromagnetic field spatial distribution Active 31-Dec-2023
WO-2025145171-A1 Method and system to determine radio frequency antenna electromagnetic field spatial distribution Inactive 31-Dec-2023
US-20250213119-A1 Method and system for enhancing rf energy delivery during thermoacoustic imaging Inactive 30-Dec-2023
WO-2025145136-A1 Method and system for enhancing rf energy delivery during thermoacoustic imaging Inactive 30-Dec-2023
US-12350015-B2 Radio frequency applicator Active 10-Nov-2023 A61B5/0093
To view ENDRA Life Sciences’s complete patent history, request access »

ENDRA Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ENDRA Life Sciences Acquisitions (1)

ENDRA Life Sciences’s most recent deal was a Reverse Merger with Noble Africa. The deal was made on 25-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Noble Africa 25-Jun-2026 Reverse Merger Holding Companies
To view ENDRA Life Sciences’s complete acquisitions history, request access »

ENDRA Life Sciences ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

36.29 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view ENDRA Life Sciences’s complete esg history, request access »

ENDRA Life Sciences FAQs

  • When was ENDRA Life Sciences founded?

    ENDRA Life Sciences was founded in 2007.

  • Where is ENDRA Life Sciences headquartered?

    ENDRA Life Sciences is headquartered in Ann Arbor, MI.

  • What is the size of ENDRA Life Sciences?

    ENDRA Life Sciences has 11 total employees.

  • What industry is ENDRA Life Sciences in?

    ENDRA Life Sciences’s primary industry is Diagnostic Equipment.

  • Is ENDRA Life Sciences a private or public company?

    ENDRA Life Sciences is a Public company.

  • What is ENDRA Life Sciences’s stock symbol?

    The ticker symbol for ENDRA Life Sciences is NDRA.

  • What is the current stock price of ENDRA Life Sciences?

    As of 19-Nov-2026 the stock price of ENDRA Life Sciences is $3.70.

  • What is the current market cap of ENDRA Life Sciences?

    The current market capitalization of ENDRA Life Sciences is $5.55M.

  • Who are ENDRA Life Sciences’s competitors?

    SigTuple, TeraRecon, Rivanna (Diagnostic Equipment), Niramai, and iCAD are some of the 18 competitors of ENDRA Life Sciences.

  • What is ENDRA Life Sciences’s annual earnings per share (EPS)?

    ENDRA Life Sciences’s EPS for 12 months was -$5.25.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process